Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Nov;7(5):393-409.
doi: 10.2174/187152708786927877.

Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse

Affiliations
Review

Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse

J Zhu et al. CNS Neurol Disord Drug Targets. 2008 Nov.

Abstract

A number of studies over the last two decades have demonstrated the critical importance of dopamine (DA) in the behavioral pharmacology and addictive properties of abused drugs. The DA transporter (DAT) is a major target for drugs of abuse in the category of psychostimulants, and for methylphenidate (MPH), a drug used for treating attention deficit hyperactivity disorder (ADHD), which can also be a psychostimulant drug of abuse. Other drugs of abuse such as nicotine, ethanol, heroin and morphine interact with the DAT in more indirect ways. Despite the different ways in which drugs of abuse can affect DAT function, one evolving theme in all cases is regulation of the DAT at the level of surface expression. DAT function is dynamically regulated by multiple intracellular and extracellular signaling pathways and several protein-protein interactions. In addition, DAT expression is regulated through the removal (internalization) and recycling of the protein from the cell surface. Furthermore, recent studies have demonstrated that individual differences in response to novel environments and psychostimulants can be predicted based on individual basal functional DAT expression. Although current knowledge of multiple factors regulating DAT activity has greatly expanded, many aspects of this regulation remain to be elucidated; these data will enable efforts to identify drugs that might be used therapeutically for drug dependence therapeutics.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Two-dimensional representation of dopamine transporter topology based on LeuT structure. Twelve transmembrane domains are shown with helically unwound regions in the first and sixth domain; extracellular and intracellular loops include helical portions (e2, e3, e4a, e4b, and i1, 15, respectively) (see [122]). The residues mutation of which are discussed in the text are shown in colored circles: W84 in TM1b, red; D313 in TM6a, red; and Y335 in TM6b, green. The respective conformationally biased mutants are W84L and D313N (outward facing, [123]), and Y335A (inward facing, [126]).

References

    1. Giros B, Caron MG. Trends Pharmacol Sci. 1993;14(2):43. - PubMed
    1. Dani JA, Zhou FM. Neuron. 2004;42(4):522. - PubMed
    1. Koob GF, Bloom FE. Science. 1988;242(4879):715. - PubMed
    1. Seeman P, Niznik HB. Faseb J. 1990;4(10):2737. - PubMed
    1. Fiorino DF, Coury A, Fibiger HC, Phillips AG. Behav Brain Res. 1993;55(2):131. - PubMed

Publication types

MeSH terms